Usefulness of traditional serum biomarkers for management of breast cancer patients.

Usefulness of traditional serum biomarkers for management of breast cancer patients.

Item
http://www.wikidata.org/entity/Q37375636
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patientsSerum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients.Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast CancerPostoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence.Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion.Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.Increased circulating M2-like monocytes in patients with breast cancer.Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis
P2860

Usefulness of traditional serum biomarkers for management of breast cancer patients.

Item
http://www.wikidata.org/entity/Q37375636
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@en
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@nl
type
label
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@en
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@nl
prefLabel
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@en
Usefulness of traditional serum biomarkers for management of breast cancer patients.
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
Usefulness of traditional serum biomarkers for management of breast cancer patients
@en
P2093
P275
P2860
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932